Chol
Chol
Chol
CHOD
Cholesterol esters+H2O Cholesterol + fatty acids
CE Blank Standard Specimen
Cholesterol +O2 Cholest-4-ene-3-one+H2O2
POD
2 H2O2+ 4-AAP + Phenol Quinoneimine dye + 4 H2O R2 1.0 ml 1.0 ml 1.0 ml
Standard …… 10 µl ……
The intensity of the color produced is directly proportional to cholesterol Specimen …… …… 10 µl
concentration. It is determined by measuring the increase in absorbance at
500 – 550 nm.
0 0
EXPECTED VALUES Mix, incubate for 5 minutes at 37 C or 10 minutes at 20-25 C. Measure
the absorbance of specimen (Aspecimen) and standard (Astandard) against
reagent blank.
Risk classification Total Cholesterol
The color is stable for 60 minutes.
Desirable <200 mg/dl (5.2 mmol/l)
Borderline high 200 – 239 mg/dl • Automated Procedure
(5.2 – 6.2 mmol/l) User defined parameters for different auto analyzers are available
High >240 mg/dl (6.2 mmol/l) upon request
CALCULATION
Each laboratory should investigate the transferability of the expected Calculate the cholesterol concentration by using the following
values to its own patient population and if necessary determine its own formulae:
reference range. For diagnostic purposes, the cholesterol results
Cholesterol Concentration=
should always be assessed in conjunction with the patient’s medical
history, clinical examination, and other findings. Absorbance of Specimen X Standard value
Absorbance of Standard
www.nsbiotec.com 1 of 2 Rev.4-2011
Unit conversion BIBLIOGRAPHY
mg/dl x 0.0259 = mmol/l
1. Searcy, RL (1969): Diagnostic Biochemistry. McGraw-Hill, New York, NY.
LINEARITY
2. Ellefson, RD and Garaway, WT (1976): Fundamentals of clinical
When run as recommended, the assay is linear up to 800 mg/dl (20.7 chemistry. Ed Tietz NW, p 506.
mmol/l).
3. Lieberman, C. (1885): Ber. 18: 1803.
If result exceeds 800 mg/dl (20.7 mmol/l), specimen should be diluted
4. Burchard, H (1890): Chem. Zentr. 61: 25.
with 0.9% NaCl solution and reassayed. Multiply the result by the
5. Flegg, HM (1973): Ann. Clin. Biochem. 10: 79.
dilution factor.
6. Richmond, W (1972): Scand. J. Cal. Invest. 29 (Suppl): 126.
SENSITIVITY
7. Hernandez, HH and Chaikoff, IL (1957): J. Biol. Chem. 228: 447.
The sensitivity is defined as the change of analytical response per unit
change in analyte concentration at a pathlength of 1 cm. 8. Hyun, J, et al., (1969): J. Biol. Chem. 244: 1937.
When run as recommended the sensitivity of this assay is 3.0 mg/dl 9. Allain, CC, et al., (1974): Clin. Chem. 20: 470.
(0.08 mmol/l). 10. Roeschlau, P, Bernt, E and Gruber, F (1974): Clin. Chem. Clin.
Biochem. 12: 226.
QUALITY CONTROL
11. Trinder, P (1969): Ann. Clin. Biochem. 6: 24.
It is recommended that controls (normal and abnormal) be included in:
12. Henry, RJ (1974): Clinical Chemistry: Principles and Techniques.
• Each set of assays, or Harper & Row, Hagerstown, MD.
• At least once a shift, or
13. Young, DS (1990): Effects of Drugs on Clinical Laboratory Tests. Third
• When a new bottle of reagent is used, or Edition. 1990: 3: 6-12.
• After preventive maintenance is performed or a clinical component
14. Young, DS, et al., (1975): Clin. Chem. 21: 5.
is replaced.
Commercially available control material with established cholesterol
values may be routinely used for quality control.
Failure to obtain the proper range of values in the assay of control material
may indicate:
• Reagent deterioration,
• Instrument malfunction, or
• Procedure errors.
The following corrective actions are recommended in such situations:
• Repeat the same controls.
• If repeated control results are outside the limits, prepare fresh
control serum and repeat the test.
• If results on fresh control material still remain outside the limits,
then repeat the test with fresh reagent.
• If results are still out of control, contact NS Biotec Technical
Services.
INTERFERING SUBSTANCES
• Anticoagulants
The only acceptable anticoagulants are heparin and EDTA.
• Bilirubin:
Bilirubin levels higher than 7.5 mg/dl decrease the apparent total
cholesterol concentration significantly.
• Drugs:
Methyldopa causes artificially low total cholesterol values at the
tested drug level. For a more comprehensive review of drugs
13
affecting cholesterol assays refer to the publication by Young .
• Haemoglobin:
No interference from haemoglobin up to a level of 500 mg/dl.
• Lipemia:
No significant interference.
• Others: N.S BIOTEC
Ascorbic acid levels higher than 7.5 mg/dl decrease the apparent
MEDICAL EQUIPMENTS
total cholesterol concentration significantly.
Other 3-beta-hydroxysteroids cause positive interference but are
7 Sad Zaghloul sq. Mehatet Elraml, Wellkang Ltd
14
not normally present in significant quantities in human serum . Alexandria – Egypt suite B , 29 Harley
WARNING & PRECAUTIONS Tele: 002 03 486 5140 street LONDON ,
Fax: 002 03 485 7597 W 1 G 9 QR , U.K.
• NS Biotec cholesterol reagent is for in vitro diagnostic use only. Website : www.nsbiotec.com www.CE-marking .EU
Normal precautions exercised in handling laboratory reagents should E- mail : [email protected]
be followed.
• Warm up working solution to the corresponding temperature before
use.
• The reagent and sample volumes may be altered proportionally to
accommodate different spectrophotometer requirements.
• Valid results depend on an accurately calibrated instrument,
timing, and temperature control.
• The reagent blank will not exceed an absorbance of 0.06 but
don’t use the reagent if it is turbid or if the absorbance is
greater than 0.2 at 500 nm.
www.nsbiotec.com 2 of 2 Rev.4-2011